skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Search for: All records

Creators/Authors contains: "Gao, Leiwen"

Note: When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external site maintained by the publisher. Some full text articles may not yet be available without a charge during the embargo (administrative interval).
What is a DOI Number?

Some links on this page may take you to non-federal websites. Their policies may differ from this site.

  1. null (Ed.)
  2. Abstract Disease mapping is an important statistical tool used by epidemiologists to assess geographic variation in disease rates and identify lurking environmental risk factors from spatial patterns. Such maps rely upon spatial models for regionally aggregated data, where neighboring regions tend to exhibit similar outcomes than those farther apart. We contribute to the literature on multivariate disease mapping, which deals with measurements on multiple (two or more) diseases in each region. We aim to disentangle associations among the multiple diseases from spatial autocorrelation in each disease. We develop multivariate directed acyclic graphical autoregression models to accommodate spatial and inter‐disease dependence. The hierarchical construction imparts flexibility and richness, interpretability of spatial autocorrelation and inter‐disease relationships, and computational ease, but depends upon the order in which the cancers are modeled. To obviate this, we demonstrate how Bayesian model selection and averaging across orders are easily achieved using bridge sampling. We compare our method with a competitor using simulation studies and present an application to multiple cancer mapping using data from the Surveillance, Epidemiology, and End Results program. 
    more » « less